60-year-old Woman with Fever, Chills and Hematochezia
Clinical Case:
A 60-year-old Italian-speaking woman with chronic lymphoblastic
leukemia presents with a 3-day history of fever, chills and hematochezia.
Initially she was seen in the oncology clinic, started on ciprofloxacin
and metronidazole and sent immediately to the emergency. She was
diagnosed with CLL 9 years ago and had received radiotherapy and
various chemotherapy agents. Most recently she received fludarabine
and cyclophosphamide one month ago.
On examination she had a temperature of 39.4°C with a blood
pressure of 100/70 and heart rate of 120 bpm. The neurologic examination
was normal and she did not have signs of meningismus. There was
marked abdominal lymphadenopathy and prolapsed hemorrhoids that
were most likely the cause of the blood in her stool.
Her routine blood work was normal. There was no growth from her
urine culture. However, gram-positive bacilli were seen in one
out of two blood culture bottles after one day of incubation.
The bacteria were described as small coccobacilli in short chains.
(Figure 1)
The patient was immediately switched to ampicillin 2g IV q4h
and gentamicin 80mg IV q8h. She quickly improved and was stepped
down to just ampicillin for a total of two weeks. Upon further
questioning, it was revealed that in the week prior to her illness
she ingested unpasteurized goat cheese imported from Italy.
Figures:
|
Figure 1: Gram Stain of Isolate reveals
gram-positive bacilli. |
Questions:
- What is the bacterium found in her blood? What diseases can
this bacterium cause?
- Where is this bacterium normally found? How does it cause
disease in humans? Which populations are at most risk? What
advice would you give this patient upon discharge?
- Describe the mechanism of pathogenesis at the cellular and
molecular level.
- How would you confirm the identity of this organism?
- What antibiotics can be used against this bacterium? Which
common antibiotics have no activity against it?
Discussion:
Listeria monocytogenes is a facultative anaerobic gram-positive
rod that can cause serious infections in humans and animals. While
it is well known as an animal pathogen, L. monocytogenes
is a relatively rare cause of human illness. L. monocytogenes
is ubiquitous in nature as a soil organism and has many opportunities
to enter the human foodchain. The pathogenesis of listeriosis
depends on the ability of the organism to survive and replicate
inside host cells including macrophages. L. monocytogenes
was discovered by Murray, Webb and Swann in 1926 during an outbreak
among lab rabbits and guinea pigs in Cambridge, England. This
new species was originally named Bacterium monocytogenes because
of a profound mononuclear leucocytosis observed in infected animals.
It should be noted that while mononuclear leucocytosis is a characteristic
of some animal infections, it is not a normal feature of human
listeriosis. Other names were also used including Erysipelothrix
and Listerella before Listeria was finally adopted in 1927 to
honor Dr. Joseph Lister, the English surgeon who discovered antisepsis.
L. monocytogenes primarily causes meningitis,
encephalitis and septicemia especially in the elderly or persons
with lower cell-mediated immunity. It can start with non-sepcific
symptoms of fever, malaise and myalgia or gastrointestinal symptoms
before progressing to a more serious illness such as meningitis
in predisposed individuals. Focal infections are rare but can
occur in the immunocompromised through seeding during the bacteremic
phase of the infection. These include endocarditis, endophthalmitis,
septic arthritis, osteomyelitis, liver abscesses, cholecystitis,
peritonitis and pleuropulmonary infection. Cutaneous infections
are also possible in healthy people who have had skin contact
with L. monocytogenes.
In pregnant women, L. monocytogenes causes
a flu-like illness that can lead to infection of the fetus. Perinatal
infections can lead to abortion, stillbirth or delivery of a seriously
ill baby with early onset listeriosis characterized by pneumonia,
septicemia and disseminated abscesses. Neonatal listeriosis usually
occurs term babies who are infected days to weeks post-delivery
and presents with meningitis rather than septicemia.
While most cases are sporadic, outbreaks have been
documented. Foods that have been implicated include coleslaw,
soft cheeses, pate, poultry, turkey frankfurters, mushrooms, milk
and pork tongue in jelly. A transient carrier state can occur
in 2 to 20% of animals and humans. Factors that are important
in establishing infection include the host immune status, gastric
acidity and inoculum size.
L. monocytogenes is a facultative intracellular
pathogen that can survive inside host macrophages. It is believed
that the bacteria penetrate the intestinal epithelium through
specialized epithelial cells overlying the Peyer’s patches
called M cells. After invading and replicating in the epithelial
and phagocytic cells, it spreads to the liver and spleen through
the bloodstream. Most are killed in the liver within the first
6 hours. However, if any bacteria survive, the liver becomes the
primary site of replication for the bacteria. Subsequently they
disseminate hematogenously preferentially to the brain and placenta
to cause a more serious disease. Its ability to survive inside
phagocytic cells is thought to allow entry past the blood-brain
barrier and the transplacental barrier.
L. monocytogenes is also able to spread from
cell to cell without entering the extracellular environment. To
invade host cells, L. monocytogenes binds to a host receptor
called E-cadherin via a bacterial ligand called internalin. After
entry into the host cell, it resides in a vesicle. Then it must
produce a hemolysin called listeriolysin to lyse the phagosome
and escape into the cytoplasm where it can replicate. Through
the expression of a protein called ActA, it can then harness the
host cell’s actin machinery to move inside the cytoplasm.
Upon reaching the cell membrane, it can cause the pseudopod-like
protrusions that reach out to neighboring cells. Through an unknown
mechanism, the bacterium induces the neighboring cell to engulf
the pseudopod containing the bacterium. It ends up in a second
phagosome and the life cycle is repeated. Thus it can spread from
one cell to the next while avoiding the host humoral immune response.
Listeriae are gram-positive non-sporulating bacilli
or coccobacilli occurring singly or in short chains. Occasionally
palisades and Y-form patterns can lead to confusion with Corynebacterium.
The occasional rod over 10 µm resembles Erysipelothrix
and coccoid forms can be mistaken for Streptococci. Confirmation
of the identity requires isolation and culture. Colonies are small,
smooth and grayish in color. L. monocytogenes exhibits
tumbling motility at ambient temperatures (20 to 25°C) due
to the presence of up to four peritrichous flagella. It is also
catalase positive, oxidase negative, hydrolyzes esculin, and has
positive Voges-Proskauer and methyl red reactions. L. monocytogenes
produces a hemolysin resulting in β-hemolysis on sheep blood
agar plates. A synergistic hemolysis also occurs with β-lysin-producing
Staphylococcus aureus in the CAMP test. A DNA probe assay
is available for confirmation of colonies on primary plates. Though
not commercially available, PCR-based tests have been shown to
be highly sensitive and specific for detecting L. monocytogenes
in CSF and tissue.
The pattern of antibiotic susceptibility has remained
unchanged for many years. Penicillin or ampicillin with or without
an aminoglycoside is generally recommended for treatment of listeriosis.
Penicillin alone is bacteriostatic against Listeria but an aminoglycoside
can enhance the activity of penicillin against L. monocytogenes.
Trimethoprim-sulphamethoxazole alone has also been used with success
in listeriosis. Resistance to chloramphenicol, macrolides and
tetracyclines has been reported in some clinical isolates. However,
L. monocytogenes is intrinsically resistant to cephalosporins
and these agents should never be used if Listeria is suspected.
References:
- Centers for Disease Control and Prevention. 2002.
Listeriosis. Centers for Disease Control and Prevention, Atlanta,
GA.
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/listeriosis_g.htm
- Canadian Food Inspection Agency. 2001. Food safety
facts on Listeria. Ottawa, Canada.
http://www.inspection.gc.ca/english/corpaffr/foodfacts/listeriae.shtml
- Ryser, E.T. and Marth, E.H. 1999. Listeria,
Listeriosis, and Food Safety, Volume 92. Marcel Dekker, Inc.,
New York.